Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Reactive clones (RSV, HCV, CMV, Parechovirus, C. difficile, S. aureus)
- Development stage
- Preclinical
- Lead developer
- Kling Biotherapeutics
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Kling Biotherapeutics (formerly AIMM Therapeutics) is developing a panel of fully human monoclonal antibody clones targeting a range of infectious pathogens, including Respiratory Syncytial Virus (RSV), Hepatitis C Virus (HCV), Cytomegalovirus (CMV), Parechovirus, *Clostridioides difficile*, and *Staphylococcus aureus*. These antibodies are derived from "elite responders"—patients who have exhibited exceptional natural immune responses—using the company's proprietary Kling-Select and Kling-Evolve technologies. The program is currently in the discovery phase, aiming to identify potent neutralizing antibodies that can be developed for the treatment or prevention of these viral and bacterial infections.
- Other names
- Reactive clones
02
Targets
RSV G (Respiratory syncytial virus attachment glycoprotein)
Beyond the preview
Go deeper on Reactive clones (RSV, HCV, CMV, Parechovirus, C. difficile, S. aureus).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reactive clones (RSV, HCV, CMV, Parechovirus, C. difficile, S. aureus).